v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 590,479,000 $ 604,787,000
Accounts receivable(1), net of allowances of $4,378 and $2,755 at September 30, 2026 and December 31, 2025, respectively [1] 380,744,000 311,170,000
Inventory 53,773,000 51,724,000
Related party asset 17,500,000 8,785,000
Prepaid expenses and other current assets 47,507,000 40,498,000
Marketable equity securities 46,874,000 150,211,000
Total current assets 1,136,877,000 1,167,175,000
Property and equipment, net 95,186,000 89,156,000
Goodwill 488,142,000 470,211,000
Intangible assets, net 293,815,000 349,202,000
Capitalized software, net 40,561,000 6,051,000
Marketable equity securities, less current portion 212,276,000 0
Investments and other assets 16,241,000 21,111,000
Investment in joint venture 77,635,000 86,557,000
Investment in related party 17,500,000 0
Related party asset, less current portion 10,208,000 16,215,000
Operating lease right-of-use assets 58,402,000 64,496,000
Restricted cash 4,755,000 4,664,000
Total Assets 2,451,598,000 2,274,838,000
Current Liabilities    
Accounts payable 70,506,000 81,994,000
Related party payable 10,000,000 0
Accrued expenses 232,976,000 155,370,000
Deferred revenue [2] 85,931,000 92,673,000
Deferred other income [3] 11,966,000 15,955,000
Other current liabilities 12,146,000 8,680,000
Operating lease liabilities 11,584,000 13,355,000
Accrued data licensing fees 1,296,000 4,361,000
Total current liabilities 436,405,000 372,388,000
Operating lease liabilities, less current portion 69,483,000 74,272,000
Convertible promissory note 175,967,000 208,672,000
Other long-term liabilities 51,449,000 56,600,000
Revolving credit facility 0 100,000,000
Interest payable 22,501,000 12,393,000
Long-term debt, net 0 202,753,000
Convertible senior notes, net 1,174,877,000 728,078,000
Deferred other income, less current portion [4] 0 7,977,000
Deferred revenue, less current portion 20,514,000 20,379,000
Total Liabilities 1,951,196,000 1,783,512,000
Commitments and contingencies
Convertible redeemable preferred stock, $0.0001 par value, 20,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively, no shares outstanding at September 30, 2026 and December 31, 2025 0 0
Stockholders' equity    
Treasury Stock, 203,431 and 183,229 shares at September 30, 2026 and December 31, 2025, respectively, at cost (6,642,000) (6,642,000)
Additional paid-in capital 3,037,849,000 2,892,910,000
Accumulated other comprehensive income 166,000 902,000
Accumulated deficit (2,530,990,000) (2,395,862,000)
Total Stockholders' equity 500,402,000 491,326,000
Total Liabilities, Convertible redeemable preferred stock, and Stockholders' equity 2,451,598,000 2,274,838,000
Common Class A [Member]    
Stockholders' equity    
Common stock value issued 18,000 17,000
Common Class B [Member]    
Stockholders' equity    
Common stock value issued $ 1,000 $ 1,000
[1] Includes related party accounts receivable from Pathos AI, Inc. of $12,092 and $6,428 as of September 30, 2026 and December 31, 2025, respectively. Refer to Note 16, Related Parties. Also includes related party accounts receivable from SB Tempus Corp. of $318 and $173 as of September 30, 2026 and December 31, 2025, respectively. Refer to Note 7, Joint Venture.
[2] Includes related party deferred revenue from Pathos AI, Inc. of $103 and $3,938 as of September 30, 2026 and December 31, 2025, respectively. Refer to Note 16, Related Parties. Also includes related party deferred revenue from SB Tempus Corp. of $0 and $6,235 as of September 30, 2026 and December 31, 2025, respectively. Refer to Note 7, Joint Venture.
[3] Deferred other income balances solely related to SB Tempus Corp. Refer to Note 7, Joint Venture
[4] Deferred other income balances solely related to SB Tempus Corp. Refer to Note 7, Joint Venture.